155 related articles for article (PubMed ID: 34031189)
41. Ebselen alters cellular oxidative status and induces endoplasmic reticulum stress in rat hippocampal astrocytes.
Santofimia-Castaño P; Izquierdo-Alvarez A; de la Casa-Resino I; Martinez-Ruiz A; Perez-Lopez M; Portilla JC; Salido GM; Gonzalez A
Toxicology; 2016 May; 357-358():74-84. PubMed ID: 27282967
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the antimicrobial activity of ebselen: role of the yeast plasma membrane H+-ATPase.
Chan G; Hardej D; Santoro M; Lau-Cam C; Billack B
J Biochem Mol Toxicol; 2007; 21(5):252-64. PubMed ID: 17912695
[TBL] [Abstract][Full Text] [Related]
43. The 14-3-3 protein affects the conformation of the regulatory domain of human tyrosine hydroxylase.
Obsilova V; Nedbalkova E; Silhan J; Boura E; Herman P; Vecer J; Sulc M; Teisinger J; Dyda F; Obsil T
Biochemistry; 2008 Feb; 47(6):1768-77. PubMed ID: 18181650
[TBL] [Abstract][Full Text] [Related]
44. The inhibition of mammalian 15-lipoxygenases by the anti-inflammatory drug ebselen: dual-type mechanism involving covalent linkage and alteration of the iron ligand sphere.
Walther M; Holzhütter HG; Kuban RJ; Wiesner R; Rathmann J; Kühn H
Mol Pharmacol; 1999 Jul; 56(1):196-203. PubMed ID: 10385701
[TBL] [Abstract][Full Text] [Related]
45. Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections.
Thangamani S; Younis W; Seleem MN
Sci Rep; 2015 Jun; 5():11596. PubMed ID: 26111644
[TBL] [Abstract][Full Text] [Related]
46. Antioxidant and anti-mutagenic effects of ebselen in yeast and in cultured mammalian V79 cells.
Miorelli ST; Rosa RM; Moura DJ; Rocha JC; Lobo LA; Henriques JA; Saffi J
Mutagenesis; 2008 Mar; 23(2):93-9. PubMed ID: 18267951
[TBL] [Abstract][Full Text] [Related]
47. In vitro glutathione peroxidase mimicry of ebselen is linked to its oxidation of critical thiols on key cerebral suphydryl proteins - A novel component of its GPx-mimic antioxidant mechanism emerging from its thiol-modulated toxicology and pharmacology.
Kade IJ; Balogun BD; Rocha JB
Chem Biol Interact; 2013 Oct; 206(1):27-36. PubMed ID: 23933410
[TBL] [Abstract][Full Text] [Related]
48. Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells.
Thangamani S; Eldesouky HE; Mohammad H; Pascuzzi PE; Avramova L; Hazbun TR; Seleem MN
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3002-3010. PubMed ID: 27712973
[TBL] [Abstract][Full Text] [Related]
49. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
[TBL] [Abstract][Full Text] [Related]
50. The neuroprotective agent ebselen modifies NMDA receptor function via the redox modulatory site.
Herin GA; Du S; Aizenman E
J Neurochem; 2001 Sep; 78(6):1307-14. PubMed ID: 11579139
[TBL] [Abstract][Full Text] [Related]
51. Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.
Billack B; Santoro M; Lau-Cam C
Microb Drug Resist; 2009 Jun; 15(2):77-83. PubMed ID: 19432523
[TBL] [Abstract][Full Text] [Related]
52. Monomeric 14-3-3ζ has a chaperone-like activity and is stabilized by phosphorylated HspB6.
Sluchanko NN; Artemova NV; Sudnitsyna MV; Safenkova IV; Antson AA; Levitsky DI; Gusev NB
Biochemistry; 2012 Aug; 51(31):6127-38. PubMed ID: 22794279
[TBL] [Abstract][Full Text] [Related]
53. Lithium Pharmacogenetics: Where Do We Stand?
Pisanu C; Melis C; Squassina A
Drug Dev Res; 2016 Nov; 77(7):368-373. PubMed ID: 27633500
[TBL] [Abstract][Full Text] [Related]
54. Phosphomimicking mutations of human 14-3-3ζ affect its interaction with tau protein and small heat shock protein HspB6.
Sluchanko NN; Sudnitsyna MV; Chernik IS; Seit-Nebi AS; Gusev NB
Arch Biochem Biophys; 2011 Feb; 506(1):24-34. PubMed ID: 21081103
[TBL] [Abstract][Full Text] [Related]
55. Ebselen rescues oxidative-stress-suppressed osteogenic differentiation of bone-marrow-derived mesenchymal stem cells via an antioxidant effect and the PI3K/Akt pathway.
Li Y; Chen G; He Y; Zhang X; Zeng B; Wang C; Yi C; Yu D
J Trace Elem Med Biol; 2019 Sep; 55():64-70. PubMed ID: 31345368
[TBL] [Abstract][Full Text] [Related]
56. Ebselen by modulating oxidative stress improves hypoxia-induced macroglial Müller cell and vascular injury in the retina.
Tan SM; Deliyanti D; Figgett WA; Talia DM; de Haan JB; Wilkinson-Berka JL
Exp Eye Res; 2015 Jul; 136():1-8. PubMed ID: 25912997
[TBL] [Abstract][Full Text] [Related]
57. Unusually short chalcogen bonds involving organoselenium: insights into the Se-N bond cleavage mechanism of the antioxidant ebselen and analogues.
Thomas SP; Satheeshkumar K; Mugesh G; Guru Row TN
Chemistry; 2015 Apr; 21(18):6793-800. PubMed ID: 25766307
[TBL] [Abstract][Full Text] [Related]
58. Investigating the effects of ebselen, a potential new lithium mimetic, on glutamate transmission.
Mota F; Sementa T; Taddei C; Moses N; Bordoloi J; Hader S; Eykyn T; Cash D; Turkheimer F; Veronese M; Singh N
Synapse; 2020 Jul; 74(7):e22151. PubMed ID: 32056277
[TBL] [Abstract][Full Text] [Related]
59. Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE).
AbdelKhalek A; Abutaleb NS; Mohammad H; Seleem MN
PLoS One; 2018; 13(6):e0199710. PubMed ID: 29953486
[TBL] [Abstract][Full Text] [Related]
60. Identification of methionine aminopeptidase 2 as a molecular target of the organoselenium drug ebselen and its derivatives/analogues: Synthesis, inhibitory activity and molecular modeling study.
Węglarz-Tomczak E; Burda-Grabowska M; Giurg M; Mucha A
Bioorg Med Chem Lett; 2016 Nov; 26(21):5254-5259. PubMed ID: 27692546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
